MaxCyte Company Insiders

MaxCyte Management Team Effectiveness

The company has return on total asset (ROA) of (0.1367) % which means that it has lost $0.1367 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2319) %, meaning that it created substantial loss on money invested by shareholders. MaxCyte's management efficiency ratios could be used to measure how well MaxCyte manages its routine affairs as well as how well it operates its assets and liabilities. MaxCyte maintains a total of 106.67 Million outstanding shares. The majority of MaxCyte outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in MaxCyte to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in MaxCyte. Please pay attention to any change in the institutional holdings of MaxCyte as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

MaxCyte Workforce Comparison

The company has Profit Margin (PM) of (1.33) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.62) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.62.

MaxCyte Insider Trading

MaxCyte Notable Stakeholders

String symbol = request.getParameter("s");

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

When running MaxCyte's price analysis, check to measure MaxCyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MaxCyte is operating at the current time. Most of MaxCyte's value examination focuses on studying past and present price action to predict the probability of MaxCyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MaxCyte's price. Additionally, you may evaluate how the addition of MaxCyte to your portfolios can decrease your overall portfolio volatility.